"Tennessee families with seriously ill children are

New Post Public Reply Private Reply Replies (1) Message Board
bellsandwhistles
"Tennessee families with seriously ill children are fleeing the state for Colorado"

(When Big Pharma owns a state. Senator Lamarr Alexander from Tennessee, high ranking and powerful, was the fourth highest recipient of Big Pharma campaign "contributions" in 2013-2014. Tennesseans take second billing as the most over-medicated people in the US. More prescriptions per capita are written in Tennessee than in 48 states. According to Pro Publica's "Dollars for Docs," Big Pharma owns influential Tennessean medical professionals, paying them millions of dollars to salute and advocate the newest Big Pharma drugs to their fellow professionals and professional associations. In 2009, key Tennessee doctors received about $8mil for Big Pharma advocacy. In 2012 , doctors nationwide received $2 billion in direct payments and gratuities from 15 big drugmakers.)

Medical Marijuana And The Need To Leave Tennessee

by Abby White
Jan 23, 2014

Tennessee families with seriously ill children are fleeing the state for Colorado, where they'll have access to medical marijuana. The Mattison family left Nashville last week, and are settling into Colorado Springs with their three children, Neal (10), Sam (7) and Millie (22 months). Millie has been suffering infantile spasms since she was three months old and is already taking an adult dosage of her current medication. When her doctors wanted to increase the dosage further — with little hope for improvement — the Mattisons started researching medical marijuana.

Why?

Part of the answer, from today's Scene piece:

Millie sees a neurologist at the Neurometabolic Clinic at the Cincinnati Children's Hospital every three months. Between visits to Cincinnati, Millie frequents the emergency room at Vanderbilt. But the cause of her seizures is still unknown.

She's endured intubations, blood transfusions, spinal taps, MRIs, CAT scans, genetic testing and stints in the pediatric intensive care unit, one due to kidney shutdown from an anti-seizure ketogenic diet. She's been on as many as 11 medications at one time and relies upon a feeding tube. Her current medication, Sabril, leaves her lethargic and has severe potential side effects, including blindness.

"One study we looked at said that if two anti-epileptics don't work, there's a 10 percent chance that any of them will work," Penn says. "If four don't work, there's a 0.8 percent chance. We've been on six. Nothing has really helped that much. She sleeps 20, 22 hours a day — there's no way she can build any muscle tone or development skills.

Although HB 1385, also known as the Koozer-Kuhn Medical Cannabis Act, was presented by state Rep. Sherry Jones (D-Nashville) on 07 January, it stands little chance of passing. (courtesy of Big Pharma)

Paul Kuhn, whose wife Jeanne found relief in medical marijuana before she passed away from cancer in 1996, is the former national chairman of the lobbying group National Organization for the Reform of Marijuana Laws. Despite the current political climate and opposition to the bill, Kuhn, who continues to serve on NORML's board, is optimistic about HB 1385.

"It will pass," Kuhn states, with a confidence many sympathetic voters don't share. "We're very close to the tipping point. There will be, this year, probably five to eight additional states that pass. So do we want Tennessee to be holding up the rear? It doesn't do our state image any good to be the laggers in a very progressive movement."

On Monday, January 27, a symposium "Koozer-Kuhn: Re-establishing a Medical Cannabis Program in Tennessee" will be held at Vanderbilt Owen School of Management from 7-8:30 pm, featuring speeches from legislators and patients. This is an 80-seat hall and audio will be broadcast in adjacent rooms to handle overflow.


Big Pharma

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Centrus Energy's Quarter Ups and Downs Unpacked

Updated Category News Views 19

Stirring the Pot: Centrus Energy's Rollercoaster Quarter Trading never fails to serve up surprises, and Centrus Energy Corp. (NYSE:LEU) is dishing them out this quarter. Despite a revenue slip to $55.5 million from last year’s $74.9 million, GAAP net income rocketed to a whopping $31.6 million. Talk about a mixed bag of fortunes. Diving Deeper into the Numbers Revenue...

Continue Reading
Gates Unveils Poly Chain® Carbon™: A Game Changer?

Updated Category News Views 24

Rethinking Industrial Chains with Poly Chain® Carbon ONE Amid today's relentless industrial landscape, Gates Industrial Corporation is stepping into the spotlight by debuting the Poly Chain® Carbon™ ONE. This ain't just another product release—it's a full-throttle attempt to shake up the heavy-duty power transmission industry. Stakeholders, take note: this launch...

Continue Reading
MY DR NOW Expands: Seven-Day Clinics Open Everywhere

Updated Category News Views 48

Breaking The Mold Of Traditional Medicine MY DR NOW isn't here to play by the age-old rules. They're slinging open the doors to their newest family medicine clinics and kicking the old Monday-to-Friday scheduling straight to the curb. Every single day of the week, from 8 a.m. to 8 p.m., patients in Sunnyvale and Tucson are getting a dose of healthcare that's all about...

Continue Reading
Belay Diagnostics Clinches Second Palantir Title

Updated Category News Views 45

Innovation in Liquid Biopsy Lands Belay Another Win Another round of applause is due for Belay Diagnostics, the brainy bunch in molecular diagnostics focused on CSF liquid biopsy for CNS cancers. This Chicago-based powerhouse clinched its second consecutive victory at the Palantir Foundry Buildcamp competition. The team must be on some winning streak, as they're not just...

Continue Reading
Life with PAH: A Journey of Awareness and Hope

Updated Category News Views 230

Unearthing the Hidden Struggle of PAH The American Lung Association (ALA) is getting loud about a quiet killer—pulmonary arterial hypertension (PAH) is in their spotlight this month, and it's about time. Documenting the horror stories of some 500 to 1,000 new PAH diagnoses each year in the U.S., the ALA is peeling back the blinds on a condition that's too often...

Continue Reading
Menarini & Ryvu's Phase II Results Offer Hope in B-NHL

Updated Category News Views 113

New Glimmers of Hope in B-cell NHL Battle Battling aggressive B-cell non-Hodgkin lymphoma (B-NHL) isn't for the faint of heart, especially when standard treatments have been run through like an old pair of boots. Enter dapolsertib, the fresh-faced newcomer in Menarini Group and Ryvu Therapeutics' arsenal, showing encouraging signals in early Phase II results. These...

Continue Reading
Peabody's Q3 2026: Margins Climb Despite Net Loss

Updated Category News Views 26

Tough Quarters but Promising Margins Alright, Peabody's Q3 2026 isn't the most sunshine-filled report I've laid eyes on, but it's not all shadows either. Sure, they posted a net loss of $32.8 million, better than last year's $70.1 million drain. Admit it or not, that's improvement. And yet, the real gem here is those expanding margins gleaming despite the loss-heavy...

Continue Reading
Kaolin Market Surges to $8.89B by 2031: Key Trends

Updated Category News Views 113

Riding the Kaolin Wave: Industrial Market Expansion You can't miss the sound of kaolin clinking in as it rides the tide of industrial demand. Reports from MarketsandMarkets™ have kaolin's party rocking all the way to a hefty $8.89 billion by 2031, up from $6.19 billion in 2026. With a sensible 7.5% compound annual growth rate (CAGR), this clay’s is aiming for the...

Continue Reading
P.C. Richard & Son's Generations+: Loyalty Rewarded

Updated Category News Views 60

What's the Deal with Generations+ at P.C. Richard & Son? Felt like companies were giving away the farm just to keep customers hooked, and then I heard about P.C. Richard & Son's latest play. They've been around for a scorching 117 years, and now they're offering something they've never done before: a free membership program called Generations+ that tosses perks like candy...

Continue Reading
AlphaESS Stretches Influence with Adriatic Energy Boost

Updated Category News Views 103

AlphaESS Charges into the Adriatic Region Kicking off with a bang in Zagreb, AlphaESS didn't just show up at the Green Energy Fair 2026—they turned the spotlights on their expanding role across the Adriatic region. This ain't your run-of-the-mill industry showcase. They've been busy throwing up energy storage units like they're growing crops. With a strong lineup...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Exciting Partnership Between Domino's and Netflix

Updated Category News Views 257

Exciting Collaboration: Domino's Pizza and Netflix Domino's Pizza Inc. (NYSE: DPZ) has teamed up with Netflix Inc. (NASDAQ: NFLX) in a thrilling initiative that merges the worlds of pizza and entertainment. This unique partnership aims to highlight how Emergency Pizza can make a difference, particularly for fans navigating the intense challenges of the popular show, Squid...

Continue Reading
Understanding Rep. Robert Bresnahan's Recent Alibaba Stock Purchase

Updated Category News Views 236

Rep. Robert Bresnahan's Investment in Alibaba Group Holdings Recently, Representative Robert Bresnahan made headlines through a reported stock purchase in Alibaba Group Holdings (NASDAQ: BABA). This acquisition, valued between $7,007 and $105,000, signals a notable move by the congressman aimed at capitalizing on the potential growth of this tech giant. The report...

Continue Reading
SP Group A/S Unveils Strategic Share Buy-Back Initiative

Updated Category News Views 122

SP Group A/S Launches Share Buy-Back Programme SP Group A/S has recently taken a significant step aimed at enhancing shareholder value through a newly initiated share buy-back programme. This initiative is indeed a forward-looking strategy designed to make the most of the financial market conditions present. Details of the Buy-Back Programme According to the established...

Continue Reading
Concerns Grow Over Anti-Fluoride Actions and Public Health

Updated Category News Views 166

Concerns Grow Over Anti-Fluoride Actions and Public Health Tooth decay remains a prevalent issue for many, representing the most common chronic disease among children and adults across the United States. Health experts, including Health and Human Services Secretary Robert F. Kennedy Jr., emphasize the need for federal health agencies to prioritize disease prevention,...

Continue Reading
Future Trends of CNC Tool Grinders Market Growth Insights

Updated Category News Views 209

CNC Tool Grinders Market Overview The global CNC tool grinders market is set for impressive growth. Increased demand for precision tooling across various industries, such as aerospace and automotive, is a main driver. The market value is expected to rise significantly, indicating strong growth potential for stakeholders involved in this field. Growth Projections and...

Continue Reading